Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;42(11):e181-e182.
doi: 10.2337/dc19-0891. Epub 2019 Sep 23.

Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)

Collaborators, Affiliations

Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT)

Lily Agrawal et al. Diabetes Care. 2019 Nov.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier analysis of time to renal composite from randomization in the VADT to end of 15 years (15 November 2000–30 June 2017). The x-axis shows “subjects at risk” at each year since randomization in the INT and STD cohorts. HR 0.81, 95% CI 0.68, 0.97; P = 0.02.

References

    1. Afkarian M, Zelnick LR, Hall YN, et al. . Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016;316:602–610 - PMC - PubMed
    1. Reaven PD, Emanuele NV, Wiitala WL, et al. .; VADT Investigators . Intensive glucose control in patients with type 2 diabetes - 15-year follow-up. N Engl J Med 2019;380:2215–2224 - PMC - PubMed
    1. Astor BC, Matsushita K, Gansevoort RT, et al. .; Chronic Kidney Disease Prognosis Consortium . Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011;79:1331–1340 - PMC - PubMed
    1. Agrawal L, Azad N, Bahn GD, et al. .; VADT Study Group . Long-term follow-up of intensive glycaemic control on renal outcomes in the Veterans Affairs Diabetes Trial (VADT). Diabetologia 2018;61:295–299 - PMC - PubMed
    1. Lawrence L, Menon V, Kashyap S. Cardiovascular and renal outcomes of newer anti-diabetic medications in high-risk patients. Curr Cardiol Rep 2018;20:65. - PubMed